Work

Dupilumab-treated patients with moderate-to-severe asthma are more likely to meet clinical remission criteria: results from the VESTIGE trial

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.pa1202

Authors: Njira Lugogo, Alberto Papi, Mario Castro, Celeste Porsbjerg, Christopher E Brightling, Arnaud Bourdin, Claudia Chavez Loureiro, Mei Zhang, Xavier Soler, Paul J Rowe, Yamo Deniz, Lucia De Prado Gomez, Harry Sacks, Juby Jacob-Nara

Institutions: University of Michigan, University of Ferrara, Frederiksberg Hospital, Bispebjerg Hospital, University of Leicester, NIHR Leicester Biomedical Research Centre, Centre National de la Recherche Scientifique, Inserm, Université de Montpellier, Physiologie et Médecine Expérimentale du Coeur et des Muscles, Unidade Local de Saúde de Coimbra, Sanofi (United States), Regeneron (United States)

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404101143

Cites:

Cited by:

Related to: 10